Bharatam PV - Search Results

1

3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors.

Singh SK, Dessalew N, Bharatam PV. Singh SK, et al. Among authors: bharatam pv. Eur J Med Chem. 2006 Nov;41(11):1310-9. doi: 10.1016/j.ejmech.2006.06.010. Epub 2006 Aug 4. Eur J Med Chem. 2006. PMID: 16890327

2

3D-QSAR studies of pyruvate dehydrogenase kinase inhibitors based on a divide and conquer strategy.

Aboye TL, Sobhia ME, Bharatam PV. Aboye TL, et al. Among authors: bharatam pv. Bioorg Med Chem. 2004 May 15;12(10):2709-15. doi: 10.1016/j.bmc.2004.03.019. Bioorg Med Chem. 2004. PMID: 15110852

3

Comparative molecular similarity indices analysis (CoMSIA) studies of 1,2-naphthoquinone derivatives as PTP1B inhibitors.

Sobhia ME, Bharatam PV. Sobhia ME, et al. Among authors: bharatam pv. Bioorg Med Chem. 2005 Mar 15;13(6):2331-8. doi: 10.1016/j.bmc.2004.12.039. Bioorg Med Chem. 2005. PMID: 15727882

4

Additivity of molecular fields: CoMFA study on dual activators of PPARalpha and PPARgamma.

Khanna S, Sobhia ME, Bharatam PV. Khanna S, et al. Among authors: bharatam pv. J Med Chem. 2005 Apr 21;48(8):3015-25. doi: 10.1021/jm049383s. J Med Chem. 2005. PMID: 15828840

5

Pharmacophoric features of biguanide derivatives: an electronic and structural analysis.

Bharatam PV, Patel DS, Iqbal P. Bharatam PV, et al. J Med Chem. 2005 Dec 1;48(24):7615-22. doi: 10.1021/jm050602z. J Med Chem. 2005. PMID: 16302801

6

3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.

Dessalew N, Patel DS, Bharatam PV. Dessalew N, et al. Among authors: bharatam pv. J Mol Graph Model. 2007 Mar;25(6):885-95. doi: 10.1016/j.jmgm.2006.08.009. Epub 2006 Sep 3. J Mol Graph Model. 2007. PMID: 17018257

7

Investigation of potential glycogen synthase kinase 3 inhibitors using pharmacophore mapping and virtual screening.

Dessalew N, Bharatam PV. Dessalew N, et al. Among authors: bharatam pv. Chem Biol Drug Des. 2006 Sep;68(3):154-65. doi: 10.1111/j.1747-0285.2006.00430.x. Chem Biol Drug Des. 2006. PMID: 17062013

8

Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.

Kumar R, Ramachandran U, Khanna S, Bharatam PV, Raichur S, Chakrabarti R. Kumar R, et al. Among authors: bharatam pv. Bioorg Med Chem. 2007 Feb 1;15(3):1547-55. doi: 10.1016/j.bmc.2006.06.063. Epub 2006 Dec 12. Bioorg Med Chem. 2007. PMID: 17166722

9

3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors.

Singh SK, Dessalew N, Bharatam PV. Singh SK, et al. Among authors: bharatam pv. Med Chem. 2007 Jan;3(1):75-84. doi: 10.2174/157340607779317517. Med Chem. 2007. PMID: 17266627

10

3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.

Dessalew N, Bharatam PV. Dessalew N, et al. Among authors: bharatam pv. Eur J Med Chem. 2007 Jul;42(7):1014-27. doi: 10.1016/j.ejmech.2007.01.010. Epub 2007 Jan 24. Eur J Med Chem. 2007. PMID: 17335939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters